The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis

Imbert, O, Deckx, H, Bernard, K et al. (7 more authors) (2021) The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis. Osteoarthritis and Cartilage Open, 3 (4). 100209. ISSN 2665-9131

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 Galapagos NV. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International (OARSI). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Knee osteoarthritis; Cartilage; Clinical trial; Disease modification; Quantitative magnetic resonance imaging; ADAMTS-5 inhibitor
Dates:
  • Accepted: 13 August 2021
  • Published (online): 16 August 2021
  • Published: December 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 13 Sep 2021 10:43
Last Modified: 13 Sep 2021 10:56
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ocarto.2021.100209

Download

Export

Statistics